A biotech aiming to revolutionize the treatment of inflammatory diseases with novel serotonin 5-HT2A agonists on a proprietary platform built to achieve anti-inflammatory efficacy at very low “micro” doses. 2A Biosciences is a pharmaceutical company that develops drugs with small molecules focusing on inflammation using 2A agonists.